Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

NCT00863551 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00863551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00863551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2009
Completion date
August 31, 2009
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly, overactive bladder, pharmacokinetics